Researchers Find Possible New Route to Making Cancer Cells Vulnerable

DURHAM, N.C. -- Researchers at the Howard Hughes Medical Institute at Duke University Medical Center have shown how drugs that stop organ transplant rejection also partially reverse drug resistance in certain cancer cells.

Such resistance, which thwarts cancer chemotherapy, is a principal cause of death for cancer patients. The scientists have identified a new target to stop drug resistance in cancer cells. The researchers believe the finding will help scientists develop new compounds to prevent drug resistance in patients with cancer, but without compromising the immune system.

"We may have identified an Achilles' heel in the body's natural reaction in expelling toxic drugs," said geneticist Dr. Joseph Heitman, the study's principal investigator.

The research was supported in part by the National Institute of Environmental Health Sciences and a Rhone Poulenc Rorer Hematology Scholar award to colleague Dr. Charles Hemenway.

Heitman and Hemenway, both researchers in Duke's Comprehensive Cancer Center, reported their findings in the Aug. 2 issue of the Journal of Biological Chemistry. They found that three drugs given to stop organ transplant rejection -- cyclosporin, FK506, and rapamycin -- also block the cellular pump that expels cancer chemotherapy drugs. But it turns out the drugs block the pump by different mechanisms.

Previously, scientists believed the anti-rejection drugs acted like sludge in a gas tank, clogging the pump mechanism. But the Duke scientists showed that FK506 and rapamycin also tie up a separate protein, called FKBP12, which they showed is an essential activator for the pump to work correctly. In other words, the two drugs primarily halt the cellular pump by removing a vital part, like a valve from a car's fuel pump.

"Cyclosporin-related drugs are now being tested for their ability to reverse chemotherapy resistance in cancer patients, but little

Contact: Karyn Hede George
Duke University

Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:

(Date:5/21/2020)... ... May 20, 2020 , ... ... for drugs, biologics, cell and gene therapies, and consumer health products, today announced ... will be presenting at the ISCT 2020 Paris Virtual conference, which takes place ...
(Date:5/15/2020)... Md. (PRWEB) , ... May 15, 2020 , ... The ... boutique intellectual property law firm based in Frederick, Maryland and Tysons Corner, Virginia, to ... field of biotechnology and a another in the field of chemistry. The firm is ...
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary ... found the 2019 average medical sales rep total compensation increased by $12,000 over ... amid the COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... ... device, diagnostics, and animal health markets, has enabled Cytovale, Inc., a medical technology ... and machine learning, to achieve their first patient in (FPI) in just seven ...
(Date:5/26/2020)... ... 2020 , ... Brilliant , the leading smart home control and lighting ... announce a new integration to bring more convenience, simplicity, and security to the smart ... Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/21/2020)... Calif. (PRWEB) , ... May 20, 2020 , ... ... the addition of Simon Prakash, who will serve as the company’s executive vice ... at a time when Exo is disrupting the medical imaging space, bringing more ...
(Date:5/15/2020)... Mass. (PRWEB) , ... May 15, 2020 , ... Sentien ... the appointment of Richard Ganz as Executive Chairman. Mr. Ganz will continue to ... years, as well as work closely with CEO Brian Miller and Sentien’s management team. ...
Breaking Biology Technology:
Cached News: